In situ and non-cytotoxic cross-linking strategy for 3D printable biomaterials

Y Sümbelli, SE Diltemiz, MG Say, ÖB Ünlüer, A Ersöz… - Soft Matter, 2021 - pubs.rsc.org
3D bioprinting allows the production of patient-specific tissue constructs with desired
structural characteristics such as high resolution, controlled swelling degree, and controlled …
被引用次数：16 相关文章

In situ and non-cytotoxic cross-linking strategy for 3D printable biomaterials

Y Sumbelli, S Diltemiz, M Say, Ö ÜNLÜER… - SOFT …, 2021 - avesis.anadolu.edu.tr
3D bioprinting allows the production of patient-specific tissue constructs with desired
structural characteristics such as high resolution, controlled swelling degree, and controlled …

[引用][C] In situ and non-cytotoxic cross-linking strategy for 3D printable biomaterials

Y Sümbelli, S Emir Diltemiz, MG Say, ÖB Ünlüer… - Soft …, 2021 - ui.adsabs.harvard.edu
In situ and non-cytotoxic cross-linking strategy for 3D printable biomaterials - NASA/ADS Now
on home page ads icon ads Enable full ADS view NASA/ADS In situ and non-cytotoxic …

In situ and non-cytotoxic cross-linking strategy for 3D printable biomaterials

Y Sumbelli, SE Diltemiz, MG Say, OB Unluer, A Ersoz… - Soft Matter, 2021 - research.tue.nl
Abstract 3D bioprinting allows the production of patient-specific tissue constructs with
desired structural characteristics such as high resolution, controlled swelling degree, and …

In situ and non-cytotoxic cross-linking strategy for 3D printable biomaterials

Y Sumbelli, SE Diltemiz, MG Say, OB Unluer, A Ersoz… - Soft Matter, 2021 - diva-portal.org
3D bioprinting allows the production of patient-specific tissue constructs with desired
structural characteristics such as high resolution, controlled swelling degree, and controlled …

In situ and non-cytotoxic cross-linking strategy for 3D printable biomaterials

Y Sümbelli, SE Diltemiz, MG Say, ÖB Ünlüer… - Soft …, 2021 - pubmed.ncbi.nlm.nih.gov
3D bioprinting allows the production of patient-specific tissue constructs with desired
structural characteristics such as high resolution, controlled swelling degree, and controlled …

In situ and non-cytotoxic cross-linking strategy for 3D printable biomaterials.

Y Sümbelli, E Diltemiz, MG Say, ÖB Ünlüer, A Ersöz… - Soft Matter, 2020 - europepmc.org
3D bioprinting allows the production of patient-specific tissue constructs with desired
structural characteristics such as high resolution, controlled swelling degree, and controlled …